27
Jun 2026
New commentary published in the Journal of the Royal Society of Medicine warns that current risk-based regulatory approaches to Artificial Intelligence (AI) in healthcare fall short in protecting patients, potentially leading to over- and undertreatment as well as discrimination against patient groups.
27
Jun 2026
Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of blindness in working age adults, with promising results.
26
Jun 2026
As young adults, many millennials feared growing up more than past generations. But they've come around to it as they age, finds research published by the American Psychological Association.
26
Jun 2026
Stanford researcher Ellen Kuhl estimates that there are some 1043 potential burger recipes in the world. And with BurgerAI, a new tool developed in her lab, artificial intelligence can now design the best one for you based on your age, taste, nutritional need, and even your sustainability goal.
26
Jun 2026
A comprehensive review recently published in Current Molecular Pharmacology (2026, Volume 19, Pages 85–96) examines the rapidly evolving landscape of computational tools for predicting tumour drug resistance.
26
Jun 2026
Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.
26
Jun 2026
Through interdepartmental collaboration, a young woman's quality of life and ability to walk were restored following the laparoscopic removal of a rare, benign tumor of neurological origin in the lesser pelvis, known as a schwannoma (also called a neurinoma).
26
Jun 2026
Salmonella, an infection that causes diarrhea, fever, and abdominal pain, is the most common form of bacterial food poisoning in the U.S., sickening more than a million people each year.
26
Jun 2026
Chronic wounds remain a major healthcare challenge, especially for people with diabetes, who often experience delayed healing, persistent inflammation, and a higher risk of infection.
26
Jun 2026
A collaborative team led by Dr. Jingnan Li and Dr. Ji Li at Peking Union Medical College Hospital, together with Associate Professor Xiaohuan Guo at Tsinghua University and Academician Ye-Guang Chen at Tsinghua University School of Life Sciences, published a study in Volume 2, article number 28 of the journal Immunity & Inflammation on June 17, 2026.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
